BioNTech (Germany) Today
| 22UA Stock | 108.70 1.30 1.18% |
Performance0 of 100
| Odds Of DistressLess than 9
|
BioNTech is trading at 108.70 as of the 2nd of January 2025, a 1.18 percent decrease since the beginning of the trading day. The stock's lowest day price was 106.9. BioNTech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 13th of January 2023 and ending today, the 2nd of January 2025. Click here to learn more.
Moving against BioNTech Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioNTech Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. BioNTech's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding BioNTech or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology & Medical Research (View all Sectors) |
BioNTech SE (22UA) is traded on XETRA Stock Exchange in Germany .
BioNTech generates positive cash flow from operations, but has no cash available
Check BioNTech Probability Of Bankruptcy
BioNTech SE Risk Profiles
Although BioNTech's alpha and beta are two of the key measurements used to evaluate BioNTech's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.84 | |||
| Semi Deviation | 2.83 | |||
| Standard Deviation | 2.82 | |||
| Variance | 7.95 |
BioNTech Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioNTech without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Additional Information and Resources on Investing in BioNTech Stock
When determining whether BioNTech SE offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of BioNTech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Biontech Se Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Biontech Se Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BioNTech SE. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.